Stockreport

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit [Yahoo! Finance]

Serina Therapeutics, Inc.  (SER) 
PDF developing its proprietary POZ Platform ™ drug delivery technology, announced that Serina Therapeutics' Chief Development Officer, Randall Moreadith, MD, PhD, will be pr [Read more]